Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 45.5 | 70 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 641.0 | 60 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 8484.0 | 63 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 9698.5 | 56 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 6807.0 | 47 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 6846.0 | 60 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 6282.0 | 52 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | RANTES | 6031.0 | 61 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 202.0 | 60 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 8075.0 | 74 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 653.5 | 56 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 1835.0 | 63 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 106.5 | 74 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 6464.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 21848.0 | 63 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | RANTES | 22236.0 | 63 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 18264.0 | 59 | |
N2645 | TNF-a | 100 | ng/mL | 4 | RANTES | 19645.5 | 46 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | RANTES | 17259.0 | 62 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | RANTES | 21026.5 | 40 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | RANTES | 140.5 | 58 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | RANTES | 53.0 | 61 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | RANTES | 60.5 | 58 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | RANTES | 44.0 | 50 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | RANTES | 45.5 | 70 |